First anti-tumor drug based on KRAS G12C—AMG 510

WANG Ling-zhi, YU Fang, HE Yu-peng, LI Xing-zhou

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (5) : 31-34.

PDF(389 KB)
Welcome to visit Clinical Medication Journal!
PDF(389 KB)
Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (5) : 31-34. DOI: 10.3969/j.issn.1672-3384.2020.05.006
Drugs in the Future

First anti-tumor drug based on KRAS G12C—AMG 510

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 18(5): 31-34 https://doi.org/10.3969/j.issn.1672-3384.2020.05.006

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(389 KB)

Accesses

Citation

Detail

Sections
Recommended

/